Patent Description:
With the rapid development of clinical technologies, in routine tests using a large number of automated blood cell analyzers, automation and intelligence of devices are increasingly improved, which improves the efficiency of tests and reduces the working intensity of staff. Meanwhile, the blood cell analyzers can still only be used as a screening means in morphological examination. When suspicious conditions are encountered, it is necessary to perform morphological examination on samples. Therefore, a procedure of a clinical laboratory is generally as follows: testing samples using a blood cell analyzer; performing slide smearing and staining for a sample that triggers retest rules pre-formulated by the laboratory; and performing morphological examination on a blood smear, and outputting an examination result.

In the above procedure, whether a retest is required depends on the test result of the blood cell analyzer. The morphological examination during the retest based on the test result can only output a qualitative result of the blood sample, and cannot output a quantitative result of the blood sample.

<CIT> relates to a blood analyzing system including a sample inserting device, a sample transporting device, a sample accommodating device, a blood cell analyzer, a smear creating device, a blood cell image display device, and a system control device. When receiving a measurement order, the system control device determines the transporting destination based on the measurement order and transmits instruction data to the sample transporting device so as to transport the sample rack to the transporting destination. The instruction data is contained in the measurement order, and such measurement order is transmitted to the blood cell analyzer of the transporting destination. The sample rack is transported to the blood cell analyzer of the transporting destination by the sample transporting device, and the sample is measured according to the measurement order by the blood cell analyzer. After the measurement is finished, the measurement result is transmitted from the blood cell analyzer to the clinical test information managing server. The clinical test information managing server determines whether a re-measurement is necessary by analyzing the measurement result of the sample obtained by the blood cell analyzer <NUM>.

<CIT> relates to a sample testing system provided with a sample putting apparatus, a sample transport apparatus, a sample transport apparatus, a sample accommodating apparatus, a sample testing apparatus, a smear slide preparing apparatus, and a system control apparatus. In the sample testing system, the testing apparatus carries out a first test (first-round test) on a sample which is transported by the transport apparatus, and then transports the sample rack in a predetermined first transport direction so as not to exceed a predetermined position of the transport apparatus until the determination of necessity for a second test (retest) is carried out. When it is determined that the retest is necessary, the sample testing system transports the sample in a second transport direction opposite to the first transport direction in order to perform the retest of the sample by the testing apparatus.

In the relevant technical solution, whether a retest is necessary is determined by test results obtained from hematology analyzer.

The invention is defined by a sample analysis system according to claim <NUM> and a corresponding sample analysis method according to claim <NUM>. Further aspects of the invention are defined in the dependent claims.

In order to make the objectives, technical solutions, and advantages of the disclosure more obvious, example embodiments according to the disclosure will be described in detail below with reference to the accompanying drawings. Apparently, the described embodiments are merely some rather than all of the embodiments of the disclosure. It should be understood that the exemplary embodiments described herein do not constitute any limitation to the disclosure. All other embodiments derived by those skilled in the art without creative efforts on the basis of the embodiments of the disclosure described in the disclosure shall fall within the scope of protection of the disclosure.

In the following description, a large number of specific details are given to provide a more thorough understanding of the disclosure. However, it is obvious to those skilled in the art that the disclosure can be implemented without one or more of these details. In other examples, to avoid confusion with the disclosure, some technical features known in the art are not described.

It should be understood that the disclosure can be implemented in different forms and should not be construed as being limited to the embodiments presented herein. On the contrary, these embodiments are provided to achieve thorough and complete disclosure and fully pass the scope of the disclosure to those skilled in the art.

The terms used herein are only intended to describe the specific embodiments and do not constitute a limitation to the disclosure. As used herein, the singular forms of "a", "an", and "the/this" are also intended to include plural forms, unless the context clearly indicates otherwise. It should also be appreciated that the terms "composed of" and/or "including", when used in the description, determine the existence of described features, integers, steps, operations, elements, and/or components, but do not exclude the existence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof. As used herein, the term "and/or" includes any and all combinations of relevant listed items.

For a thorough understanding of the disclosure, detailed steps and detailed structures will be provided in the following description to explain the technical solutions proposed by the disclosure. The preferred embodiments of the disclosure are described in detail as follows. However, in addition to these detailed descriptions, the disclosure may further have other implementations.

First, a sample analysis system according to an embodiment of the disclosure is described with reference to <FIG> is a schematic flowchart of a sample analysis system <NUM> according to an embodiment of the disclosure. As shown in <FIG>, the sample analysis system <NUM> includes one or more hematology analyzers <NUM>, a controller <NUM>, a first transport apparatus <NUM>, a sample slide preparation apparatus <NUM>, and a sample image capturing apparatus <NUM>. One of the hematology analyzers <NUM> is configured to analyze a first test blood sample of a subject to obtain a sample analysis result (for example, a blood routine test result). The controller <NUM> is configured to control the first transport apparatus <NUM> to transport the first test blood sample to the sample slide preparation apparatus <NUM>, when the sample analysis result satisfies a preset condition. The sample slide preparation apparatus <NUM> is configured to prepare a sample slide of the first test blood sample. The sample image capturing apparatus <NUM> is configured to capture a sample image of a sample region on the sample slide. The controller <NUM> is further configured to generate a retest instruction and send the retest instruction to one of the hematology analyzers <NUM>, so that said hematology analyzer retests a second test blood sample of the subject, when the sample image contains information indicating that the first test blood sample is an abnormal sample.

Herein, said hematology analyzer configured for the retest (that is, analyzing the second test blood sample) and the hematology analyzer configured for the initial test (that is, analyzing the first test blood sample) may be a same hematology analyzer or different hematology analyzers. In addition, both the second test blood sample and the first test blood sample are blood samples of the same subject, and may be from a same sample container or different sample containers.

In this embodiment of the disclosure, the sample image of the blood sample that satisfies the preset condition (for example, an output result of the hematology analyzer being abnormal) is captured by the sample image capturing apparatus <NUM> (for example, the sample slide is transported by a second transport apparatus or manually from the sample slide preparation apparatus <NUM> to the sample image capturing apparatus <NUM> so as to capture the sample image), and when the sample image contains information indicating that the blood sample is an abnormal sample (wherein the sample image may be analyzed by the sample image capturing apparatus <NUM> or by the controller <NUM> or manually, so as to determine whether the sample image contains information indicating that the blood sample is an abnormal sample), a hematology analyzer <NUM> is triggered to retest a blood sample of the same subject (wherein the blood sample to be retested may be transported by a third transport apparatus or manually to said hematology analyzer). Therefore, according to the sample analysis system <NUM> in this embodiment of the disclosure, the operation of said hematology analyzer can be controlled based on the sample image, and because the sample image of the abnormal sample contains abnormal sample information, said hematology analyzer can be controlled to perform a specific retest or test operation based on the abnormal sample information, and a more accurate test result can thus be obtained.

Specifically, the controller <NUM> may be further configured to: determine an abnormality type of the first test blood sample based on the sample image, and generate the retest instruction based on the abnormality type, wherein the retest instruction includes an instruction that causes said hematology analyzer to perform the retest under a test condition corresponding to the abnormality type of the blood sample. In this embodiment, said hematology analyzer performs the retest under the test condition corresponding to the abnormality type of the blood sample, and can implement the retest in a targeted manner, thereby outputting a more accurate test result. Generally, the hematology analyzer analyzes the first test blood sample under a first test condition, and retests the second test blood sample under a second test condition, wherein the second test condition is different from the first test condition. In other words, the test conditions under which the hematology analyzer performs the initial test and the retest on the blood samples of the same subject may be different, the test condition for the retest depends on the abnormality type of the corresponding blood sample, and thus whether the blood sample of the subject is abnormal and a specific test result (for example, a quantitative numerical result) can certainly be determined based on the retest result. The following description is given in conjunction with specific examples with reference to <FIG>.

<FIG> is an exemplary schematic diagram showing a sample image of a blood sample containing microcytes. In this embodiment of the disclosure, when an image of the blood sample captured by the sample image capturing apparatus <NUM> of the sample analysis system <NUM> is as shown in <FIG>, it can be determined that the first test blood sample contains microcytes. On this basis, the controller <NUM> may be further configured to generate the retest instruction that causes said hematology analyzer <NUM> to analyze the second test blood sample by using an optical method (the analysis herein may be referred to as platelet analysis, and because a platelet count value is high due to microcytes that may be mistaken for platelets, the platelets are retested by using the optical method). In an example, retest results are shown as particle scattergrams in <FIG>, wherein <FIG> is the scattergram of reticulocytes, and <FIG> is the scattergram of platelets. According to retest results of an optical channel of said hematology analyzer <NUM>, a platelet test result of the blood sample of the subject is normal, while initial test results, such as initial test results of an impedance channel in <FIG> show a high platelet count. Therefore, in this embodiment, the hematology analyzer <NUM> analyzes the first test blood sample by using the impedance channel (that is, the first test condition), and retests the second test blood sample by using the optical channel (that is, the second test condition), wherein the platelet test result is corrected by the retest, and an accurate platelet count result can be obtained.

<FIG> is an exemplary schematic diagram showing a sample image of a blood sample containing erythrocyte fragments. In this embodiment of the disclosure, when an image of the blood sample captured by the sample image capturing apparatus <NUM> of the sample analysis system <NUM> is as shown in <FIG>, it can be determined that the first test blood sample contains erythrocyte fragments. Based on this, the controller <NUM> may be further configured to generate the retest instruction that causes said hematology analyzer <NUM> to analyze the second test blood sample, by using an optical method (the analysis herein may be referred to as platelet analysis, and because a platelet count value is high due to erythrocyte fragments that may be mistaken for platelets, the platelets are retested by using the optical method). In an example, retest results are shown as particle scattergrams in <FIG>, wherein <FIG> is the scattergram of reticulocytes, and <FIG> is the scattergram of platelets. According to a retest result of the optical channel of said hematology analyzer <NUM>, a platelet test result of the blood sample of the subject is normal, while initial test results, such as initial test results of the impedance channel in <FIG> show a high platelet count. Therefore, in this embodiment, the hematology analyzer <NUM> analyzes the first test blood sample by using the impedance channel (that is, the first test condition), and retests the second test blood sample by using the optical channel (that is, the second test condition), wherein the platelet test result is corrected by the retest, and an accurate platelet count result can be obtained.

<FIG> is an exemplary schematic diagram showing a sample image of a blood sample containing large platelets. In this embodiment of the disclosure, when an image of the blood sample captured by the sample image capturing apparatus <NUM> of the sample analysis system <NUM> is as shown in <FIG>, it can be determined that the first test blood sample contains large platelets. Based on this, the controller <NUM> may be further configured to generate the retest instruction that causes said hematology analyzer <NUM> to analyze the second test blood sample by using the optical method (the analysis herein may be referred to as platelet analysis, and because a platelet count value is low due to large platelets that may be mistaken for erythrocytes, the platelets are retested by using the optical method). In an example, retest results are shown as particle scattergrams in <FIG>, wherein <FIG> is the scattergram of reticulocytes, and <FIG> is the scattergram of platelets. According to a retest result of the optical channel of said hematology analyzer <NUM>, a platelet test result of the blood sample of the subject is normal, while initial test results, such as initial test results of the impedance channel in <FIG> show a low platelet count. Therefore, in this embodiment, the hematology analyzer <NUM> analyzes the first test blood sample by using the impedance channel (that is, the first test condition), and retests the second test blood sample by using the optical channel (that is, the second test condition), wherein the platelet test result is corrected by the retest, and an accurate platelet count result can be obtained.

In another embodiment, the controller <NUM> may be further configured to generate the retest instruction that causes said hematology analyzer <NUM> to analyze the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is at least one of a sample having a low platelet value, a sample having platelet aggregation, and a sample having leukocyte fragments. This embodiment is similar to the examples described above with reference to <FIG>, the initial test results may be inaccurate due to interference caused by various reasons, and the retest results may correct the initial test results.

In still another embodiment, the controller <NUM> may be further configured to generate the retest instruction that causes said hematology analyzer <NUM> to treat the second test blood sample with a platelet disaggregation reagent, when it is determined, based on the sample image, that the first test blood sample is a sample having a low platelet value or a sample having platelet aggregation. The platelet disaggregation reagent is a reagent capable of inhibiting platelet aggregation. It is difficult to obtain an accurate platelet count result of the platelet aggregation sample due to platelet aggregation, and a low platelet count result may also be obtained for a sample having a low platelet value due to platelet aggregation. Therefore, in this embodiment, the second test blood sample may be treated with the platelet disaggregation reagent and then tested by using the optical method or the impedance method to obtain an accurate test result.

In still another embodiment, the controller <NUM> may be further configured to generate the retest instruction that causes said hematology analyzer <NUM> to analyze erythrocytes in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having erythrocyte aggregation. When the blood sample is a sample having erythrocyte aggregation, it indicates that erythrocyte aggregation occurs in the blood sample, which will affect the counting accuracy of erythrocytes. Therefore, in this embodiment, the blood sample is retested by using the optical method that is not affected by the aggregation, so that an accurate erythrocyte count result can be obtained.

In still another embodiment, the controller <NUM> may be further configured to generate the retest instruction that causes the hematology analyzer <NUM> to analyze hemoglobin in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having a falsely elevated hemoglobin. When the blood sample is a sample having a falsely elevated hemoglobin, it indicates that there is chylous blood in the blood sample, which will affect the determination of a hemoglobin value. Therefore, in this embodiment, the blood sample is retested by using the optical method that is not affected by chylous blood, so that an accurate hemoglobin value can be obtained.

In still another embodiment, the controller <NUM> may be further configured to generate the retest instruction that causes said hematology analyzer <NUM> to count leukocytes in the second test blood sample by using a leukocyte differential channel, when it is determined, based on the sample image, that the first test blood sample is a sample having leukocyte aggregation. When the blood sample is a sample having leukocyte aggregation, it indicates that leukocyte aggregation occurs in the blood sample. In this case, the counting accuracy of leukocytes is affected if a complete blood count channel (CBC channel) that performs weak hemolysis on cells and is likely to cause leukocyte aggregation is used. Therefore, in this embodiment, the blood sample is retested by using a leukocyte differential channel (DIFF channel) that performs strong hemolysis on cells and is not affected by aggregation, so that an accurate leukocyte count result can be obtained.

In the above embodiments, if the initial test is performed by using the optical method (for example, both the impedance method and the optical method are used), and when it is determined that the first test blood sample is at least one of sample having a low platelet value, a sample having platelet aggregation, a sample having erythrocyte fragments, a sample having leukocyte fragments, a sample having microcytes, and a sample having large platelets, a sample having erythrocyte aggregation, a sample having a falsely elevated hemoglobin, and a sample having leukocyte aggregation, the retest instruction may be outputting the test result of the optical method.

The above shows examples in which the controller <NUM> determines the abnormality type of the first test blood sample based on the sample image, and generates, based on the abnormality type, the instruction that causes the hematology analyzer <NUM> to perform the retest under the test condition corresponding to the abnormality type of the blood sample.

In an embodiment of the disclosure, the controller <NUM> may be a central controller that may be further configured to: obtain the sample image from the sample image capturing apparatus <NUM>, analyze the sample image, and generate the retest instruction and send the retest instruction to one hematology analyzer <NUM> (said hematology analyzer may be the hematology analyzer for performing the initial test or may be another one different from it), so that said hematology analyzer performs the retest, when it is determined, based on the analysis, that the sample image contains information indicating that the first test blood sample is an abnormal sample.

In another embodiment of the disclosure, the controller <NUM> may be integrated into the sample image capturing apparatus <NUM>, and the controller <NUM> may be further configured to: obtain the sample image, analyze the sample image, and generate the retest instruction and send the retest instruction to one hematology analyzer <NUM> (said hematology analyzer may be the hematology analyzer for performing the initial test or may be another one different from it), so that said hematology analyzer performs the retest, when it is determined, based on the analysis, that the sample image contains information indicating that the first test blood sample is an abnormal sample.

In still another embodiment of the disclosure, the controller <NUM> may be integrated into one hematology analyzer <NUM> (said hematology analyzer may be the hematology analyzer for performing the initial test or may be another one different from it), and the controller <NUM> may be further configured to: obtain the sample image from the sample image capturing apparatus <NUM>, analyze the sample image, and generate the retest instruction to control said hematology analyzer <NUM> (said hematology analyzer may be the hematology analyzer for performing the initial test or may be another one different from it) to perform the retest, when it is determined, based on the analysis, that the sample image contains information indicating that the first test blood sample is an abnormal sample.

In yet another embodiment of the disclosure, the controller <NUM> may be integrated into the sample slide preparation apparatus <NUM>, and the controller <NUM> may be further configured to: obtain the sample image, analyze the sample image, and generate the retest instruction and send the retest instruction to the hematology analyzer <NUM> (said hematology analyzer may be the hematology analyzer for performing the initial test or may be another one different from it), so that said hematology analyzer performs the retest, when it is determined, based on the analysis, that the sample image contains information indicating that the first test blood sample is an abnormal sample.

In this embodiment of the disclosure, the controller <NUM> may include at least: a processing component, a random access memory (RAM), a read-only memory (ROM), a communication interface, a memory, and an output/input (I/O) interface, wherein the processing component, the RAM, the ROM, the communication interface, the memory, and the I/O interface communicate through a bus. The processing component may be a central processing unit (CPU), a graphics processing unit (GPU), or other chips with computing capabilities. An operating system, and various computer programs such as an application program executable by the processing component, and data required for execution of the computer programs are stored in the memory. In addition, in the process of sample testing, any data that needs to be stored locally may be stored in the memory. The I/O interface is composed of a serial interface such as a USB, IEEE1394 or RS-232C, a parallel interface such as an SCSI, IDE or IEEE1284, and an analog signal interface composed of a D/A converter, A/D converter, and the like. An input device composed of a keyboard, a mouse, a touchscreen, or other control buttons is connected to the I/O interface, and a user may directly input data to a control device by using the input apparatus. In addition, the I/O interface may be further connected to a display with a display function, for example: a liquid crystal display, a touchscreen, an LED display, etc., and the control device may output the processed data as image display data to the display for displaying, for example, analysis data and an instrument operating parameter. The communication interface may be an interface which supports any currently known communication protocol. The communication interface communicates with the outside over a network. The controller <NUM> may transmit data with any device connected over the network through the communication interface and based on a communication protocol.

The sample analysis system <NUM> according to an embodiment of the disclosure is exemplarily described above. Based on the above description, according to the sample analysis system <NUM> in this the embodiment of the disclosure, the hematology analyzer first performs the initial test on the blood sample of the subject, the sample image capturing apparatus captures the sample image when the initial test result satisfies the preset condition, and generates the retest instruction when the sample image contains information indicating that the sample is an abnormal sample, such that the hematology analyzer retests the blood sample of the subject according to the instruction. In this way, the operation of the hematology analyzer can be controlled based on the sample image and because the sample image of the abnormal sample contains abnormal sample information, the hematology analyzer can be controlled to perform a specific retest operation based on the abnormal sample information, and a more accurate test result can thus be obtained.

A sample analysis system according to another embodiment of the disclosure will be described below with reference to <FIG> is a schematic flowchart of a sample analysis system <NUM> according to another embodiment of the disclosure. As shown in <FIG>, the sample analysis system <NUM> includes a sample image capturing apparatus <NUM>, a controller <NUM>, and a hematology analyzer <NUM>. The sample image capturing apparatus <NUM> is configured to capture a sample image of a sample region on a sample slide, the sample slide being prepared from a first test blood sample of a subject. The controller <NUM> is configured to generate a test instruction and send the test instruction to the hematology analyzer <NUM>, so that the hematology analyzer <NUM> analyzes a second test blood sample of the subject, when the sample image contains information indicating that the first test blood sample is an abnormal sample. The hematology analyzer <NUM> is configured to analyze the second test blood sample, so as to obtain a sample analysis result.

The sample analysis system <NUM> according to this embodiment of the disclosure is similar to the sample analysis system <NUM> according to the embodiment of the disclosure described above in that the operation of the hematology analyzer is controlled based on the sample image, and a difference therebetween lies in that, according to the sample analysis system <NUM> in the embodiment of the disclosure described above, a hematology analyzer performs an initial test on the blood sample before the operation of the hematology analyzer is controlled based on the sample image, while according to the sample analysis system <NUM> in this embodiment of the disclosure, the hematology analyzer is controlled to perform an initial test directly based on the sample image. Therefore, according to the sample analysis system <NUM> in this embodiment of the disclosure, the test instruction is generated when the sample image of the blood sample contains information indicating that the sample is an abnormal sample, such that the hematology analyzer tests the blood sample of the subject according to the instruction. In this way, the operation of the hematology analyzer can be controlled based on the sample image; and because the sample image of the abnormal sample contains abnormal sample information, the hematology analyzer can be controlled to perform a specific test operation based on the abnormal sample information, and an accurate test result can thus be obtained.

Similar to the controller <NUM> in the sample analysis system <NUM>, in an embodiment, the controller <NUM> in the sample analysis system <NUM> may be further configured to: determine an abnormality type of the first test blood sample based on the sample image, and generate the test instruction based on the abnormality type, wherein the test instruction includes an instruction that causes the hematology analyzer <NUM> to perform analysis under a test condition corresponding to the abnormality type. In this embodiment, the hematology analyzer performs the test under the test condition corresponding to the abnormality type of the blood sample, and can implement the test in a targeted manner, thereby outputting an accurate test result.

Similar to the controller <NUM> in the sample analysis system <NUM>, in an embodiment, the controller <NUM> in the sample analysis system <NUM> may be further configured to generate the instruction that causes the hematology analyzer <NUM> to analyze the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is at least one of a sample having a low platelet value, a sample having platelet aggregation, a sample having erythrocyte fragments, a sample having leukocyte fragments, a sample having microcytes, and a sample having large platelets.

Similar to the controller <NUM> in the sample analysis system <NUM>, in another embodiment, the controller <NUM> in the sample analysis system <NUM> may be further configured to generate the instruction that causes the hematology analyzer <NUM> to treat the second test blood sample with a platelet disaggregation reagent, when it is determined, based on the sample image, that the first test blood sample is a sample having a low platelet value or a sample having platelet aggregation.

Similar to the controller <NUM> in the sample analysis system <NUM>, in still another embodiment, the controller <NUM> in the sample analysis system <NUM> may be further configured to generate the instruction that causes the hematology analyzer <NUM> to analyze erythrocytes in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having erythrocyte aggregation; generate the instruction that causes the hematology analyzer <NUM> to analyze hemoglobin in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having a falsely elevated hemoglobin; and generate the instruction that causes the hematology analyzer <NUM> to count leukocytes in the second test blood sample by using a leukocyte differential channel, when it is determined, based on the sample image, that the first test blood sample is a sample having leukocyte aggregation.

Similar to the controller <NUM> in the sample analysis system <NUM>, in an embodiment, the controller <NUM> in the sample analysis system <NUM> may be a central controller that may be further configured to: obtain the sample image from the sample image capturing apparatus <NUM>, analyze the sample image, and generate the test instruction and send the test instruction to the hematology analyzer <NUM>, so that the hematology analyzer <NUM> performs the analysis, when it is determined, based on the analysis, that the sample image contains information indicating that the first test blood sample is an abnormal sample. In another embodiment, the controller <NUM> may be integrated into the sample image capturing apparatus <NUM>, and the controller <NUM> is further configured to: obtain the sample image, analyze the sample image, and generate the test instruction and send the test instruction to the hematology analyzer <NUM>, so that the hematology analyzer <NUM> performs the analysis, when it is determined, based on the analysis, that the sample image contains information indicating that the first test blood sample is an abnormal sample. In still another embodiment, the controller <NUM> may be integrated into the hematology analyzer <NUM>, and the controller <NUM> may be further configured to: obtain the sample image from the sample image capturing apparatus <NUM>, analyze the sample image, and generate the test instruction to control the hematology analyzer <NUM> to perform the analysis, when it is determined, based on the analysis, that the sample image contains information indicating that the first test blood sample is an abnormal sample.

The above shows the sample analysis system <NUM> according to this embodiment of the disclosure. Based on the above description, according to the sample analysis system <NUM> in this embodiment of the disclosure, the test instruction is generated when the sample image of the blood sample contains information indicating that the sample is an abnormal sample, such that the hematology analyzer tests the blood sample of the same subject according to the instruction. In this way, the operation of the hematology analyzer can be controlled based on the sample image; and because the sample image of the abnormal sample contains abnormal sample information, the hematology analyzer can be controlled to perform a specific test operation based on the abnormal sample information, and an accurate test result can thus be obtained.

According to another aspect of the disclosure, a sample analysis method is further provided. The sample analysis method may be performed by the sample analysis system <NUM> or the sample analysis system <NUM> described above and will be described below with reference to <FIG> and <FIG>.

<FIG> is a schematic flowchart of a sample analysis method <NUM> according to an embodiment of the disclosure. As shown in <FIG>, the sample analysis method <NUM> may include the following steps:.

The sample analysis method <NUM> according to this embodiment of the disclosure may be performed by the sample analysis system <NUM> according to the embodiment of the disclosure described above. Those skilled in the art can understand the detailed process of the sample analysis method <NUM> according to this embodiment of the disclosure in conjunction with the above description, and for ease of brevity, only some main operations will be described herein, and details will not be repeated.

In an embodiment of the disclosure, the method <NUM> may further include the following steps (not shown): determining an abnormality type of the first test blood sample based on the sample image, and generating the retest instruction based on the abnormality type, wherein the retest instruction includes an instruction that causes the hematology analyzer to perform a retest under a test condition corresponding to the abnormality type.

In an embodiment of the disclosure, generating a retest instruction based on the abnormality type may include: generating the retest instruction that causes the hematology analyzer to analyze the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is at least one of a sample having a low platelet value, a sample having platelet aggregation, a sample having erythrocyte fragments, a sample having leukocyte fragments, a sample having microcytes, and a sample having large platelets; and/or generating the retest instruction that causes the hematology analyzer to treat the second test blood sample with a platelet disaggregation reagent, when it is determined, based on the sample image, that the first test blood sample is a sample having a low platelet value or a sample having platelet aggregation.

In an embodiment of the disclosure, generating a retest instruction based on the abnormality type may include at least one of the following: generating the retest instruction that causes the hematology analyzer to analyze erythrocytes in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having erythrocyte aggregation; generating the retest instruction that causes the hematology analyzer to analyze hemoglobin in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having a falsely elevated hemoglobin; and generating the retest instruction that causes the hematology analyzer to count leukocytes in the second test blood sample by using a leukocyte differential channel, when it is determined, based on the sample image, that the first test blood sample is a sample having leukocyte aggregation.

In an embodiment of the disclosure, the analysis on the first test blood sample is performed under a first test condition, the retest on the second test blood sample is performed under a second test condition corresponding to the retest instruction, and the second test condition is different from the first test condition.

According to the sample analysis method <NUM> in this embodiment of the disclosure, an initial test result of the blood sample of the subject is first obtained, the sample image of the blood sample is captured when the initial test result satisfies the preset condition, and the retest instruction is generated when the sample image contains information indicating that the sample is an abnormal sample, such that the hematology analyzer retests the blood sample of the same subject according to the instruction. In this way, the operation of the hematology analyzer can be controlled based on the sample image; and because the sample image of the abnormal sample contains abnormal sample information, the hematology analyzer can be controlled to perform a specific retest operation based on the abnormal sample information, and a more accurate test result can thus be obtained.

<FIG> is a schematic flowchart of a sample analysis method <NUM> according to another embodiment of the disclosure. As shown in <FIG>, the sample analysis method <NUM> may include the following steps:.

In an embodiment of the disclosure, the method <NUM> may further include the following steps (not shown): determining an abnormality type of the first test blood sample based on the sample image, and generating the test instruction based on the abnormality type, wherein the test instruction includes an instruction that causes the hematology analyzer to perform analysis under a test condition corresponding to the abnormality type.

In an embodiment of the disclosure, generating a test instruction based on the abnormality type may further include: generating the instruction that causes the hematology analyzer to analyze the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is at least one of a sample having a low platelet value, a sample having platelet aggregation, a sample having erythrocyte fragments, a sample having leukocyte fragments, a sample having microcytes, and a sample having large platelets; and/or generating the instruction that causes the hematology analyzer to treat the second test blood sample with a platelet disaggregation reagent, when it is determined, based on the sample image, that the first test blood sample is a sample having a low platelet value or a sample having platelet aggregation.

In an embodiment of the disclosure, generating a test instruction based on the abnormality type may further include at least one of the following: generating the instruction that causes the hematology analyzer to analyze erythrocytes in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having erythrocyte aggregation; generating the instruction that causes the hematology analyzer to analyze hemoglobin in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having a falsely elevated hemoglobin; and generating the test instruction that causes the hematology analyzer to count leukocytes in the second test blood sample by using a leukocyte differential channel, when it is determined, based on the sample image, that the first test blood sample is a sample having leukocyte aggregation.

According to the sample analysis method <NUM> in this embodiment of the disclosure, the test instruction is generated when the sample image of the blood sample contains information indicating that the sample is an abnormal sample, such that the hematology analyzer tests the blood sample of the same subject according to the instruction. In this way, the operation of the hematology analyzer can be controlled based on the sample image; and because the sample image of the abnormal sample contains abnormal sample information, the hematology analyzer can be controlled to perform a specific test operation based on the abnormal sample information, and an accurate test result can thus be obtained.

According to still another aspect of the disclosure, a sample image analysis system is further provided. The sample image analysis system may implement the functions of the sample image capturing apparatus and the controller in each of the sample analysis systems <NUM> and <NUM> according to the above embodiments, and will be described below with reference to <FIG>.

<FIG> is a schematic block diagram of a structure of a sample image analysis system <NUM> according to an embodiment of the disclosure. As shown in <FIG>, the sample image analysis system <NUM> may include a sample image capturing apparatus <NUM> and a controller <NUM>, wherein the sample image capturing apparatus <NUM> is configured to capture a sample image of a sample region on a sample slide prepared from a first test blood sample of a subject; and the controller <NUM> is configured to analyze the sample image, and generate an instruction that causes a hematology analyzer to test a second test blood sample of the subject, when it is determined, based on the cell image, that the first test blood sample is an abnormal sample.

Similar to the controller <NUM> in the sample analysis system <NUM>, in an embodiment, the controller <NUM> in the sample image analysis system <NUM> may be further configured to: determine an abnormality type of the first test blood sample based on the sample image, and generate a test instruction based on the abnormality type, wherein the test instruction includes an instruction that causes the hematology analyzer to perform analysis under a test condition corresponding to the abnormality type.

Similar to the controller <NUM> in the sample analysis system <NUM>, in an embodiment, the controller <NUM> in the sample image analysis system <NUM> may be further configured to: generate the instruction that causes the hematology analyzer to analyze the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is at least one of a sample having a low platelet value, a sample having platelet aggregation, a sample having erythrocyte fragments, a sample having leukocyte fragments, a sample having microcytes, and a sample having large platelets; and/or generate the instruction that causes the hematology analyzer to treat the second test blood sample with a platelet disaggregation reagent, when it is determined, based on the sample image, that the first test blood sample is a sample having a low platelet value or a sample having platelet aggregation.

Similar to the controller <NUM> in the sample analysis system <NUM>, in an embodiment, the controller <NUM> in the sample image analysis system <NUM> may be further configured to perform at least one of the following: generating the instruction that causes the hematology analyzer to analyze erythrocytes in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having erythrocyte aggregation; generating the instruction that causes the hematology analyzer to analyze hemoglobin in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having falsely elevated hemoglobin; and generating the instruction that causes the hematology analyzer to count leukocytes in the second test blood sample by using a leukocyte differential channel, when it is determined, based on the sample image, that the first test blood sample is a sample having leukocyte aggregation.

According to the sample image analysis system <NUM> in this embodiment of the disclosure, the test instruction is generated when the sample image of the blood sample contains information indicating that the sample is an abnormal sample, such that the hematology analyzer tests the blood sample of the same subject according to the instruction. In this way, the operation of the hematology analyzer can be controlled based on the sample image; and because the sample image of the abnormal sample contains abnormal sample information, the hematology analyzer can be controlled to perform a specific test operation based on the abnormal sample information, and an accurate test result can thus be obtained.

According to yet another aspect of the disclosure, a hematology analyzer is further provided. The hematology analyzer may implement the functions of the hematology analyzer in the sample analysis system <NUM> according to the above embodiment, and will be described below with reference to <FIG>.

<FIG> is a schematic block diagram of a structure of a hematology analyzer <NUM> according to an embodiment of the disclosure. As shown in <FIG>, the hematology analyzer <NUM> may include a sampling apparatus <NUM>, a sample preparation apparatus <NUM>, a test apparatus <NUM>, and a controller <NUM>, wherein the controller <NUM> is configured to receive retest information associated with a sample slide that is sent by a sample image capturing apparatus or an instrument communicatively connected to the sample image capturing apparatus, and control the sampling apparatus <NUM>, the sample preparation apparatus <NUM>, and the test apparatus <NUM> to analyze a second test blood sample of a subject based on the received retest information, the sample slide being prepared from a first test blood sample of the subject; the sampling apparatus <NUM> is configured to sample the second test blood sample from a sample container; the sample preparation apparatus <NUM> is configured to mix the second test blood sample and a reagent to prepare a blood sample solution; and the test apparatus <NUM> is configured to test the blood sample solution to obtain a blood routine test parameter.

In an embodiment of the disclosure, the retest information received by the controller <NUM> may include a sample image obtained by capturing the sample slide by the sample image capturing apparatus. In this embodiment, the controller <NUM> may be further configured to: determine an abnormality type of the first test blood sample based on the sample image, and generate a retest instruction based on the abnormality type, wherein the retest instruction includes an instruction that causes the sample preparation apparatus <NUM> and the test apparatus <NUM> to perform a retest under a test condition corresponding to the abnormality type.

In another embodiment of the disclosure, the retest information received by the controller <NUM> may include a retest instruction generated based on the abnormality type of the first test blood sample, which is determined based on the sample image, wherein the sample image is obtained by capturing the sample slide by the sample image capturing apparatus; and the retest instruction may include an instruction that causes the sample preparation apparatus <NUM> and the test apparatus <NUM> to perform a retest under a test condition corresponding to the abnormality type. In this embodiment, the controller <NUM> may directly control the sample preparation apparatus <NUM> and the test apparatus <NUM> to perform corresponding operations based on the received instruction.

In an embodiment of the disclosure, the retest instruction may include: the retest instruction being an instruction that causes the sample preparation apparatus <NUM> and the test apparatus <NUM> to analyze the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is at least one of a sample having a low platelet value, a sample having platelet aggregation, a sample having erythrocyte fragments, a sample having leukocyte fragments, a sample having microcytes, and a sample having large platelets; and/or the retest instruction being an instruction that causes the sample preparation apparatus <NUM> to treat the second test blood sample with a platelet disaggregation reagent, and then the test apparatus <NUM> to perform analysis, when it is determined, based on the sample image, that the first test blood sample is a sample having a low platelet value or a sample having platelet aggregation.

In another embodiment of the disclosure, the retest instruction may include at least one of the following: the retest instruction being an instruction that causes the sample preparation apparatus <NUM> and the test apparatus <NUM> to analyze erythrocytes in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having erythrocyte aggregation; the retest instruction being an instruction that causes the sample preparation apparatus <NUM> and the test apparatus <NUM> to analyze hemoglobin in the second test blood sample by using an optical method, when it is determined, based on the sample image, that the first test blood sample is a sample having a falsely elevated hemoglobin; and the retest instruction being an instruction that causes the sample preparation apparatus <NUM> and the test apparatus <NUM> to count leukocytes in the second test blood sample by using a leukocyte differential channel, when it is determined, based on the sample image, that the first test blood sample is a sample having leukocyte aggregation.

In this embodiment of the disclosure, the sampling apparatus <NUM> has a pipette (for example, a sampling needle) with a pipette nozzle, and has a driving portion. The driving portion is configured to drive the pipette to quantitatively aspirate the test blood sample through the pipette nozzle. For example, the sampling needle moves under the driving of the driving portion to aspirate the test blood sample from a sample container containing the blood sample. The sample preparation apparatus <NUM> has at least one reaction cell and a reagent supply apparatus. The at least one reaction cell is configured to receive the test blood sample that is aspirated by the sampling apparatus <NUM>, and the reagent supply apparatus supplies the treatment reagent to the at least one reaction cell, so that the test blood sample that is aspirated by the sampling apparatus <NUM> is mixed with the treatment reagent supplied by the reagent supply apparatus in the reaction cell so as to prepare a sample solution to be tested. The test apparatus <NUM> is configured to test the sample solution to be tested that is prepared by the sample preparation apparatus <NUM>, so as to obtain a blood routine test parameter.

According to the hematology analyzer <NUM> in this embodiment of the disclosure, the operations of the sampling apparatus, the sample preparation apparatus, and the test apparatus included in the hematology analyzer are controlled based on the retest information (the sample image or the retest instruction generated after analyzing the sample image) associated with the sample slide and received from the sample image capturing apparatus or an instrument communicatively connected to the sample image capturing apparatus, so that the operation of the hematology analyzer is controlled based on the sample image; and because the sample image of the abnormal sample contains abnormal sample information, the hematology analyzer can be controlled to perform a specific test operation based on the abnormal sample information, and an accurate test result can thus be obtained.

Furthermore, according to the embodiments of the disclosure, a storage medium is further provided. The storage medium has program instructions stored therein, and the program instructions, when executed by a computer or processor, implement the corresponding steps of the sample analysis methods of the embodiments of the disclosure. The storage medium may include, for example, a memory card of a smart phone, a storage component of a tablet computer, a hard disk of a personal computer, a read-only memory (ROM), an erasable programmable read-only memory (EPROM), a portable compact disk read-only memory (CD-ROM), a USB memory, or any combination of the above storage media. The computer-readable storage medium may be any combination of one or more computer-readable storage media.

Furthermore, according to the embodiments of the disclosure, a computer program is further provided. The computer program may be stored in a cloud or a local storage medium. The computer program, when executed by a computer or processor, is used to implement the corresponding steps of the sample analysis methods according to the embodiments of the disclosure.

Based on the above description, according to the sample analysis system and method, the sample image analysis system, and the hematology analyzer of the embodiments of the disclosure, the retest or test instruction is generated when the sample image of the blood sample contains the information indicating that the sample is an abnormal sample, such that the hematology analyzer retests or tests the blood sample of the same subject according to the instruction. In this way, the operation of the hematology analyzer can be controlled based on the sample image; and because the sample image of the abnormal sample contains abnormal sample information, the hematology analyzer can be controlled to perform a specific retest or test operation based on the abnormal sample information, and a more accurate test result can thus be obtained.

Although the exemplary embodiments have been described here with reference to the accompanying drawings, it should be understood that the exemplary embodiments described above are merely exemplary, and are not intended to limit the scope of the disclosure thereto. Those of ordinary skill in the art may make various changes and modifications therein without departing from the scope of the disclosure as claimed in the appended claims.

Those of ordinary skill in the art would have appreciated that the units and algorithm steps of the examples described in conjunction with the embodiments disclosed herein may be implemented in electronic hardware or a combination of computer software and electronic hardware. Those skilled in the art could use different methods to implement the described functions for each particular application, but such implementation should not be considered to be beyond the scope of the disclosure.

In several embodiments provided in the disclosure, it should be understood that the disclosed apparatuses and methods may be implemented in other ways. For example, the apparatus embodiments described above are merely examples. For example, the division of units is only a logic function division. In actual implementation, there may be other division methods, for example, a plurality of units or components may be combined or integrated into another apparatus, or some features may be omitted or not implemented.

A large number of specific details are explained in this description provided herein. However, it could be understood that the embodiments of the disclosure can be practiced without these specific details. In some instances, well-known methods, structures, and technologies are not shown in detail, so as not to obscure the understanding of this description.

Various embodiments regarding components in the disclosure may be implemented in hardware, or implemented by software modules running on one or more processors, or implemented in a combination thereof. It should be understood for those skilled in the art that a microprocessor or a digital signal processor (DSP) may be used in practice to implement some or all of the functions of some modules according to this embodiment of the disclosure. The disclosure may further be implemented as a device program (e.g., a computer program and a computer program product) for executing some or all of the methods described herein. Such a program for implementing the disclosure may be stored on a computer-readable medium, or may be in the form of one or more signals. Such a signal may be downloaded from an Internet website, or provided on a carrier signal, or provided in any other form.

It should be noted that the description of the disclosure made in the above-mentioned embodiments is not to limit the disclosure, and those skilled in the art may design alternative embodiments without departing from the scope of the appended claims. In the claims, any reference signs placed between parentheses should not be construed as limitation on the claims. The disclosure may be implemented by means of hardware including several different elements and by means of an appropriately programmed computer. In unit claims listing several devices, several of these devices may be specifically embodied by one and the same item of hardware. The use of the terms "first", "second", "third", etc. does not indicate any order. These terms may be interpreted as names.

Claim 1:
A sample analysis system (<NUM>), comprising at least one hematology analyzer (<NUM>), a controller (<NUM>), a first transport apparatus (<NUM>), a sample slide preparation apparatus (<NUM>), and a sample image capturing apparatus (<NUM>), wherein
one of the at least one hematology analyzer is configured to perform an initial test on a first test blood sample of a subject, so as to analyze the first test blood sample and obtain a sample analysis result;
the controller (<NUM>) is configured to control the first transport apparatus (<NUM>) to transport the first test blood sample to the sample slide preparation apparatus (<NUM>), when the sample analysis result satisfies a preset condition which is that the output result of the haematology analyzer is abnormal;
the sample slide preparation apparatus (<NUM>) is configured to prepare a sample slide of the first test blood sample;
the sample image capturing apparatus (<NUM>) is configured to capture a sample image of a sample region on the sample slide;
characterised in that
the controller (<NUM>) is further configured to generate a retest instruction and send the retest instruction to one of the at least one hematology analyzer (<NUM>), so that said hematology analyzer (<NUM>) retests a second test blood sample of the subject, when the sample image contains information indicating that the first test blood sample is an abnormal sample.